Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer
スポンサーリンク
概要
著者
-
Hashine Katsuyoshi
Department Of Urology National Shikoku Cancer Center Hospital
-
Hashine Katsuyoshi
Department Of Urology National Hospital Organization Shikoku Cancer Center
-
Sumiyoshi Yoshiteru
Department Of Urology National Shikoku Cancer Center Hospital
-
Sumiyoshi Yoshiteru
Department Of Urology National Hospital Organization Shikoku Cancer Center
-
NAKATSUZI Hironori
Department of Urology, National Shikoku Cancer Center Hospital
-
YAMASHITA Yokihiko
Department of Urology, National Shikoku Cancer Center Hospital
-
KARASHIMA Takashi
Department of Urology, National Shikoku Cancer Center Hospital
-
Karashima Takashi
Department Of Urology National Shikoku Cancer Center Hospital
-
Yamashita Yokihiko
Department Of Urology National Shikoku Cancer Center Hospital
-
Nakatsuzi Hironori
Department Of Urology National Shikoku Cancer Center Hospital
-
Karashima Takashi
Department Of Urology Kochi Medical School
関連論文
- Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer
- Neoadijuvant flutamide monotherapy for locally confined prostate cancer
- Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer : current status and perspectives
- PRIMARY DIFFUSE LARGE CELL LYMPHOMA OF THE PENIS
- Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer
- Preliminary Results of Bladder Preservation by Concurrent Intraarterial Chemotherapy and Radiotherapy for Muscle-Invasive Bladder Cancer
- Photodynamic diagnosis of positive margin during radical prostatectomy : Preliminary experience with 5-aminolevulinic acid
- Correlation between cancer location and oncological outcome after radical prostatectomy
- Changes in perioperative management of radical prostatectomy using clinical pathways according to a standardized care plan : A multi-institutional study
- Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy : A 3-year follow-up study
- Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer : a multicenter, phase II, open-label, non-comparative, extension study in Japan
- Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma : Characterization of sorafenib-resistant cells derived from a cutaneous metastasis